video of semaglutide injection Woman Making Closeup Semaglutide Stock Footage (100% Royalty-free) 3618164517 Injecting Semaglutide

Notably, the FDA does not review or test compounded drugs

Thats my message

Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence

Treatment-emergent adverse events reported in 2 individuals in either group were injection site bruising in 9 (9.4%), back pain in 3 (3.1%), and injection site erythema, thermal burn, anxiety, and insomnia each in 2 individuals (prefilled pen group) and skin abrasion and rash each in 2 participants in the prefilled syringe group